Biomarker Diagnostics in Alzheimer’s Disease

Dear Colleagues,

Alzheimer’s disease (AD) is a chronic and debilitating neurodegenerative disease that is characterized and diagnosed clinically by progressive cognitive decline. It is well established that the pathophysiology of AD remains clinically silent for decades prior to symptomatic decline. Identifying individuals at risk of disease progression could allow for effective intervention whilst the therapeutic window remains open for preservation of quality of life. To this end, establishing biomarkers of AD can be essential in obtaining a specific molecular signature for each disease stage. Equally important is the need to develop improved diagnostic tests to interrogate biological samples for accurate detection of these disease-specific markers at an early stage and differentiate AD from other forms of dementia.

This Special Issue of Cells aims to introduce new concepts which can enhance our current understanding of AD-specific biomarkers and provide a comprehensive update on recent advances in specific techniques/scientific discoveries that can be instrumental in the early diagnosis and monitoring of disease progression. Original articles and comprehensive reviews which cover topics including candidate biomarker identification in Alzheimer’s disease, novel diagnostic methods using easily accessible biofluids, investigation of biochemical changes in the brain through imaging studies, and development of specific tests tracking AD progression are welcome.

Dr. Charles R. Harrington
Prof. Claude M. Wischik
Dr. Mohammad Arastoo
Dr. Soumya Palliyil
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.